Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Li, Xinpeng, Yuan, Naxin, Lin, Lingdan, Yin, Lixia, Qu, Yiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185803/
https://www.ncbi.nlm.nih.gov/pubmed/35720625
http://dx.doi.org/10.3892/etm.2022.11365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185803/
https://www.ncbi.nlm.nih.gov/pubmed/35720625
http://dx.doi.org/10.3892/etm.2022.11365

Ejemplares similares